CRHR2 and colitis: When it comes to the exacerbated tumorigenesis in Crhr2−/− mice tested in the AOM/DSS model, we have previously demonstrated that Crhr2 gene deletion or CRHR2 inhibitor treatment worsens DSS-induced mouse colitis [14].